Serum proteomics profiling - A young technology begins to mature

Nature Biotechnology

Volumn 23, Issue 3, 2005, Pages 291-292

  Coombes, Kevin R ^a   Morris, Jeffrey S ^a   Hu, Jianhua ^a   Edmonson, Sarah R ^b   Baggerly, Keith A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; PLASMA PROTEIN;

BIOTECHNOLOGY; EARLY DIAGNOSIS; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NOTE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY; SERUM; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS; ARTICLE; BLOOD ANALYSIS; GENE EXPRESSION PROFILING; MASS SPECTROMETRY; METABOLISM; METHODOLOGY;

BIOTECHNOLOGY; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; GENE EXPRESSION PROFILING; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 20444491386     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0305-291     Document Type: Note

References (34)

1. Petricoin, E.F. et al. Lancet 359, 572-577 (2002).
2. Sorace, J.M. & Zhan, M. BMC Bioinformatics 4, 24 (2004).
3. Baggerly, K.A., et al. Bioinformatics 20, 777-785 (2004).
4. Baggerly, K.A., et al. Signal in noise: evaluating reported reproducibility of serum proteomics tests for ovarian cancer. J. Natl. Cancer Inst, 97, in press (2005).
5. Vlahou, A. et al. Clin. Chem. 50, 1438-1441 (2004).
6. Pusztai, L. et al. Cancer 100, 1814-1822 (2004).
7. Lin, Z., Jenson, S.D., Lim, M.S. & Elenitoba-Johnson, K.S. Mod. Pathol. 17, 670-678 (2004).
8. Zhang, Z. et al. Cancer Res. 64, 5882-5890 (2004).
9. Wadsworth, J.T. et al. Clin. Cancer Res. 10, 1625-1632 (2004).
10. Soltys, S.G. et al. Clin. Cancer Res. 10, 4806-4812 (2004).
11. Xiao, Z. et al. Cancer Res. 64, 2904-2909 (2004).
12. Diamandis, E.P. Expert Rev. Mol. Diagn. 4, 575-577 (2004).
13. Diamandis, E.P. Mol. Cell Proteomics 3, 367-378 (2004).
14. Rogers, M.A. et al. Cancer Res. 63, 6971-6983 (2003).
15. Hu, J., et al. Brief. Funct. Genomic. Proteomic. 3, 322-331 (2005).
16. Baggerly, K.A., et al. Endocr. Relat. Cancer 11, 583-584 (2004).
17. Villanueva, J. et al. Anal. Chem. 76, 1560-1570 (2004).
18. Koomen, J.M. et al. Rapid Commun. Mass Spectrom. 18, 2537-1848 (2004).
19. Johnson, K.L., et al. Anal. Chem. 76, 5097-5103 (2004).
20. Grizzle, W.E. et al. Dis. Markers 19, 185-195 (2004).
21. Semmes, O.J. et al. Clin. Chem. 51, 102-112 (2005).
22. Ransohoff, D.F. Nat. Rev. Cancer 4, 309-314 (2004).
23. Petricoin, E.F. 3rd et al. J. Natl. Cancer Inst. 94, 1576-1578 (2002).
24. Conrads, T.P. et al. Endocr. Relat. Cancer 11, 163-178 (2004).
25. Fung, E.T. & Enderwick, C. Biotechniques Suppl, 34-41 (2002).
26. Yasui, Y. et al. J. Biomed. Biotechnol. 2003, 242-248 (2003).
27. Yasui, Y. et al. Biostatistics 4, 449-463 (2003).
28. Coombes, K.R. et al. Clin. Chem. 49, 1615-1623 (2003).
29. Qu, Y. et al. Biometrics 59, 143-151 (2003).
30. Coombes, K.R. et al. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform. Proteomics, in press (2005).
31. Morris, J.S., Coombes, K.R., Koomen, J., Baggerly, K.A. & Kobayashi, R. Bioinformatics, published online 26 January 2005.
32. Coombes, K.R., et al. Understanding the characteristics of mass spectrometry data through the use of simulation. Cancer informatics, in press.
33. Sauve, A.C. & Speed, T.P. Normalization, baseline correction and alignment of high-throughput mass spectrometry data Proceedings Gensips 2004, in press (2005).
34. Malyarenko, D.I. et al. Clin. Chem. 51, 65-74 (2005).